yesterday announced failure of a Phase III clinical trial of bapineuzumab for the treatment of Alzheimer disease, originally developed by Prof...Had the trial succeeded, the university could have been eligible for tens of millions of dollars in royalties.
FULL ARTICLE AT Globes Online
1 of 6
Patients with Alzheimer's and dementia are sit inside the Alzheimer foundation in Mexico City
Reuters Pfizer Inc said on Monday that its experimental Alzheimer's disease treatment failed to prove effective in one of four high-stakes late-stage trials in patients with mild to moderate forms of the memory-robbing disease. The trial involved...